Eurosurveillance banner




Announcements
Follow Eurosurveillance on Twitter: @Eurosurveillanc


In this issue


Home Eurosurveillance Edition  2012: Volume 17/ Issue 37 Article 4 Printer friendly version
Back to Table of Contents
Previous Download (pdf) Next

Eurosurveillance, Volume 17, Issue 37, 13 September 2012
Letters
Importance of standardisation of HAI definitions in interpretation of international and/or multinational prevalence studies
  1. Mater Misericordiae University Hospital, Dublin, Ireland
  2. Health Protection Surveillance Centre, Dublin, Ireland
  3. Beaumont Hospital, Dublin, Ireland

Citation style for this article: Cotter M, Donlon S, Fitzpatrick F. Importance of standardisation of HAI definitions in interpretation of international and/or multinational prevalence studies . Euro Surveill. 2012;17(37):pii=20269. Available online: http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId=20269
Date of submission: 04 September 2012

To the editor:  A recent publication by Eilers et al. reported the Dutch experience of the prevalence and determinants associated with healthcare-associated infections (HAI) in long-term care facilities [1].  Ireland also participated in the European Centre for Disease Control coordinated healthcare-associated infections in long-term care facilities (HALT) point prevalence study in 2010.  Eilers et al. reported that the prevalence of HAI in Irish long-term care facilities was 11.3%; however, this figure represents the proportion of residents that had either signs or symptoms of infection and/or were on antibiotics.  The prevalence of infection in our study was 3.7% (using adapted McGeer definitions) or 2.4% (when strictly applying the McGeer definitions) [1–3].

Eilers et al. defined infection as having a ’suspicion of infection‘, i.e. having at least one symptom or sign on the HALT score list. In our study 266 (6.4%) residents had signs or symptoms of infection and it is this figure that is perhaps more comparable than the 11.3% quoted.

The HALT study has provided, for the first time, many European countries (including Ireland) with baseline data on HAI prevalence and antimicrobial use in long-term care facilities. As long-term care facilities represent a heterogeneous group of healthcare facilities, with care ranging from social to medical, inter-facility comparisons without adjustment for case mix can be difficult. In Ireland, we have used the HALT results to draft national guidelines for antimicrobial prescribing in long-term care [4] and to inform preventative programmes at a local level.  However, surveillance definitions for HAI in this setting are not yet standardised leading to difficulties when comparing international and/or multinational studies. The proposed HALT-2 study in 2013 may be an opportunity to address this deficit.


References
  1. Eilers R, Veldman-Ariesen MJ, Haenen A, van Benthem BH. Prevalence and determinants associated with healthcare-associated infections in long-term care facilities (HALT) in the Netherlands, May to June 2010. Euro Surveill. 2012;17(34):pii=20252. Available from: http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId=20252
  2. Cotter M, Donlon S, Roche F, Byrne H, Fitzpatrick F. Healthcare-associated infection in Irish long-term care facilities: results from the First National Prevalence Study. J Hosp Infect. 2012;80(3): 212-6.
  3. McGeer A, Campbell B, Emori TG, Hierholzer WJ, Jackson MM, Nicolle LE, et al. Definitions of infection for surveillance in long-term care facilities Am J Infect Control. 1991;19(1):1-7
  4. HSE-Health Protection Surveillance Centre. Diagnosis & Management of Urinary Tract Infection in Long Term Care Residents > 65 years. Dublin:HPSC; 2011. Available from: http://www.hpsc.ie/hpsc/A-Z/MicrobiologyAntimicrobialResistance/InfectionControlandHAI/Guidelines/File,12929,en.pdf

 



Back to Table of Contents
Previous Download (pdf) Next

Disclaimer:The opinions expressed by authors contributing to Eurosurveillance do not necessarily reflect the opinions of the European Centre for Disease Prevention and Control (ECDC) or the editorial team or the institutions with which the authors are affiliated. Neither ECDC nor any person acting on behalf of ECDC is responsible for the use that might be made of the information in this journal.
The information provided on the Eurosurveillance site is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician. Our website does not host any form of commercial advertisement.

Eurosurveillance [ISSN] - ©2007-2013. All rights reserved
 

This website is certified by Health On the Net Foundation. Click to verify. This site complies with the HONcode standard for trustworthy health information:
verify here.